The simulated populations varied from general populations, to high‐risk groups (such as BRCA2 gene mutation carriers or kindreds of familial pancreatic cancer patients [FPC] or individuals with pancreatic cystic lesions), to PC patients. Here, BRCA2 is linked to pachyonychia congenita.